Literature DB >> 24034405

Successful treatment of a chronic venous leg ulcer using a topical beta-blocker.

Hadar Lev-Tov1, Sara Dahle, Joyce Moss, Roslyn R Isseroff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24034405     DOI： 10.1016/j.jaad.2013.06.003

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  10 in total

1.  Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing.

Authors:  Mohan R Dasu; Sandra R Ramirez; Thi Dinh La; Farzam Gorouhi; Chuong Nguyen; Benjamin R Lin; Chelcy Mashburn; Heather Stewart; Thomas R Peavy; Jan A Nolta; Roslyn R Isseroff
Journal:  Stem Cells Transl Med       Date:  2014-04-23       Impact factor: 6.940

2.  Topical timolol for the treatment of pyoderma gangrenosum.

Authors:  Catarina Moreira; Sofia Lopes; Maria João Cruz; Filomena Azevedo
Journal:  BMJ Case Rep       Date:  2017-01-27

3.  Acute wounding alters the beta2-adrenergic signaling and catecholamine synthetic pathways in keratinocytes.

Authors:  Raja K Sivamani; Biao Shi; Elizabeth Griffiths; Shirley M Vu; Hadar A Lev-Tov; Sara Dahle; Marianne Chigbrow; Thi Dinh La; Chelcy Mashburn; Thomas R Peavy; R Rivkah Isseroff
Journal:  J Invest Dermatol       Date:  2014-03-10       Impact factor: 8.551

4.  Absorption and Safety of Topically Applied Timolol for Treatment of Chronic Cutaneous Wounds.

Authors:  Anthony Cole Gallegos; Michael James Davis; Catherine N Tchanque-Fossuo; Kaitlyn West; Angela Eisentrout-Melton; Thomas R Peavy; Roy W Dixon; Roma P Patel; Sara Evona Dahle; Roslyn Rivkah Isseroff
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-16       Impact factor: 4.730

5.  The Beta 2 Adrenergic Receptor Antagonist Timolol Improves Healing of Combined Burn and Radiation Wounds.

Authors:  Huguette Albrecht; Hsin-Ya Yang; Maija Kiuru; Saipiroon Maksaereekul; Blythe Durbin-Johnson; Michael S Wong; Thomas R Stevenson; David M Rocke; R Rivkah Isseroff
Journal:  Radiat Res       Date:  2018-01-26       Impact factor: 2.841

Review 6.  Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

Authors:  Daniel J Yoon; Ramanjot Kaur; Anthony Gallegos; Kaitlyn West; Hsinya Yang; Saul Schaefer; Catherine Tchanque-Fossuo; Sara E Dahle; R Rivkah Isseroff
Journal:  Am J Clin Dermatol       Date:  2020-11-25       Impact factor: 7.403

Review 7.  [Mechanisms of adrenergic β-antagonist for wounds and its application prospect in diabetic foot ulcers].

Authors:  Shiyi Sun; Jing Ma; Xingwu Ran
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-12-15

8.  Efficacy and Safety of 0.25% Timolol Gel in Healing Split-Thickness Skin Graft Site.

Authors:  Amirhossein Ghanbarzamani; Ebrahim Salehifar; Abdolreza Jafarirad; Mohammad Hossein Hesamirostami; Ali Bagherzadehsaba; Majid Saeedi; Monireh Ghazaeian; Ghasemali Khorasani; Mahmood Moosazadeh
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

9.  β2-adrenoceptor activation modulates skin wound healing processes to reduce scarring.

Authors:  Gabrielle S Le Provost; Christine E Pullar
Journal:  J Invest Dermatol       Date:  2014-07-22       Impact factor: 8.551

10.  Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.

Authors:  Ramanjot Kaur; Catherine Tchanque-Fossuo; Kaitlyn West; Yasmin Hadian; Anthony Gallegos; Daniel Yoon; Ligia Ismailyan; Saul Schaefer; Sara E Dahle; R Rivkah Isseroff
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.